🇺🇸 Glucosamine and chondroitin sulfate in United States

30 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fall — 4 reports (13.33%)
  2. Off Label Use — 4 reports (13.33%)
  3. Rash — 4 reports (13.33%)
  4. Arthralgia — 3 reports (10%)
  5. Back Pain — 3 reports (10%)
  6. Headache — 3 reports (10%)
  7. Product Use Issue — 3 reports (10%)
  8. Alopecia — 2 reports (6.67%)
  9. Asthenia — 2 reports (6.67%)
  10. Balance Disorder — 2 reports (6.67%)

Source database →

Glucosamine and chondroitin sulfate in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Glucosamine and chondroitin sulfate approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Glucosamine and chondroitin sulfate in United States?

Ardabil University of Medical Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.